New T2 lesions enable an earlier diagnosis of multiple sclerosis in clinically isolated syndromes
- 25 April 2003
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 53 (5) , 673-676
- https://doi.org/10.1002/ana.10580
Abstract
In clinically isolated syndromes, the new McDonald criteria for multiple sclerosis diagnosis require new gadolinium‐enhancing lesions for dissemination in time at a 3‐month follow‐up magnetic resonance imaging scan. In a cohort of 56 patients, these criteria were specific (95%) but less sensitive (58%) for clinically definite multiple sclerosis at 3 years. If new T2 lesions were allowed as an alternative for dissemination in time, sensitivity increased (74%) with maintained specificity (92%), enabling an accurate diagnosis of multiple sclerosis in more patients. Ann Neurol 2003;53:673–676Keywords
This publication has 15 references indexed in Scilit:
- New diagnostic criteria for multiple sclerosisNeurology, 2003
- Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosisAnnals of Neurology, 2002
- Assessing the risk of early multiple sclerosis in patients with clinically isolated syndromes: the role of a follow up MRIJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosisBrain, 1993
- Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine–enhancing magnetic resonance imaging lesionsAnnals of Neurology, 1993
- Serial gadolinium‐enhanced MRI in relapsing/remitting multiple sclerosis of varying disease durationNeurology, 1992
- MRI in the diagnosis of MSNeurology, 1988
- Magnetic resonance imaging in isolated noncompressive spinal cord syndromesAnnals of Neurology, 1987
- New diagnostic criteria for multiple sclerosis: Guidelines for research protocolsAnnals of Neurology, 1983
- PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSISAnnals of the New York Academy of Sciences, 1965